Search research articles
Contact Us
Filters
Showing results (101-110 of 212) with videos related to
Page
of 22
Sort By:
Arthritis and Rheumatism
|
July 13, 2002
Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials
John A Astin, William Beckner, Karen Soeken, et al.
Clinical Medicine (London, England)
|
January 19, 2007
Systematic review of systematic reviews of acupuncture published 1996-2005
George Lewith, Brian Berman, Mike Cummings, et al.
Photodiagnosis and Photodynamic Therapy
|
September 18, 2020
Efficacy of aminolevulinic acid 20 % solution photodynamic therapy in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial
Brian Berman, Neal Bhatia, Daniel Piacquadio, et al.
International Journal of Dermatology
|
February 27, 2024
Demographics, clinical characteristics, and treatment patterns among keloid patients: United States Electronic Health Records (EHR) Database Study
Abisola Olopoenia, Yuji Yamaguchi, Elena Peeva, et al.
Journal of Drugs in Dermatology : JDD
|
February 2, 2011
Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream
C William Hanke, Neil Swanson, Suzanne Bruce, et al.
Cutis
|
December 26, 2006
Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis
Adelaide A Hebert, John Koo, Joseph Fowler, et al.
Journal of the American Academy of Dermatology
|
February 6, 2010
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles
Neil Swanson, William Abramovits, Brian Berman, et al.
The New England Journal of Medicine
|
March 16, 2012
Ingenol mebutate gel for actinic keratosis
Mark Lebwohl, Neil Swanson, Lawrence L Anderson, et al.
Cutis
|
July 30, 2010
Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS
Martha H Viera, Oliver A Perez, Jitendrakumar K Patel, et al.
Cutis
|
January 27, 2010
Ecthyma gangrenosum caused by Escherichia coli bacteremia: a case report and review of the literature
Jitendrakumar K Patel, Oliver A Perez, Martha H Viera, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 212) with videos related to
Sort By:
Page
of 22
Arthritis and Rheumatism
|
July 13, 2002
Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials
John A Astin, William Beckner, Karen Soeken, et al.
Clinical Medicine (London, England)
|
January 19, 2007
Systematic review of systematic reviews of acupuncture published 1996-2005
George Lewith, Brian Berman, Mike Cummings, et al.
Photodiagnosis and Photodynamic Therapy
|
September 18, 2020
Efficacy of aminolevulinic acid 20 % solution photodynamic therapy in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial
Brian Berman, Neal Bhatia, Daniel Piacquadio, et al.
International Journal of Dermatology
|
February 27, 2024
Demographics, clinical characteristics, and treatment patterns among keloid patients: United States Electronic Health Records (EHR) Database Study
Abisola Olopoenia, Yuji Yamaguchi, Elena Peeva, et al.
Journal of Drugs in Dermatology : JDD
|
February 2, 2011
Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream
C William Hanke, Neil Swanson, Suzanne Bruce, et al.
Cutis
|
December 26, 2006
Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis
Adelaide A Hebert, John Koo, Joseph Fowler, et al.
Journal of the American Academy of Dermatology
|
February 6, 2010
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles
Neil Swanson, William Abramovits, Brian Berman, et al.
The New England Journal of Medicine
|
March 16, 2012
Ingenol mebutate gel for actinic keratosis
Mark Lebwohl, Neil Swanson, Lawrence L Anderson, et al.
Cutis
|
July 30, 2010
Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS
Martha H Viera, Oliver A Perez, Jitendrakumar K Patel, et al.
Cutis
|
January 27, 2010
Ecthyma gangrenosum caused by Escherichia coli bacteremia: a case report and review of the literature
Jitendrakumar K Patel, Oliver A Perez, Martha H Viera, et al.
Page
of 22